The story has been updated to include comments from the company's earnings call this morning.

NEW YORK (GenomeWeb) – Exact Sciences today said that its fourth quarter revenues grew 50 percent year over year. 

For the three months ended Dec. 31, 2014, the Madison, Wis.-based molecular diagnostics company reported revenues of $1.5 million, up from $1 million in Q4 2013 and even with the average analysts' estimate. 

All revenues in the recently completed quarter derived from laboratory services, while revenues from the year-ago period derived from license fees. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.